US EditionMettler-Toledo International Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Xenon Pharmaceuticals will share updates and provide a live webcast to reach investors during the healthcare conference, which runs from January 12–15.
- On Jan. 05, 2026, Xenon Pharmaceuticals Inc. announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco starting January 12, 2026.
- The company’s pipeline shows azetukalner, lead molecule for epilepsy, MDD and bipolar depression, plus early-stage Kv7 program and NaV1.7 program for pain.
- A live audio webcast will be available on the Investors section of Xenon’s website and posted for replay, and Colleen Alabiso, Senior Vice President, Corporate Affairs, can be contacted.
- The release includes a Safe Harbor statement noting forward-looking statements are not historical fact and assume no obligation to update, cautioning investors and readers against undue reliance.
- The company lists risks including clinical studies and regulatory interactions, funding sufficiency, and other uncertainties detailed in filings with the U.S. Securities and Exchange Commission and securities commissions in British Columbia, Alberta, and Ontario, noting dates and times are subject to change.
13 Articles
13 Articles
The Hamilton Spectator
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
TEL AVIV, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13,…
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
NORWOOD, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced...
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
LOS ANGELES, CA - January 5, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, announced that it will attend the JP Morgan 2026 Annual Healthcare Conference taking place Jan. 12-15, 2026, at the Westin St. Francis Hotel in San Francisco, where Chief Executive Officer Robert Eno and Chief Financial Officer Timothy Cruickshank will be available Jan. …
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
